2m 2m 2m 2m 2m 2m 2m
ACUMEN PHARMA (ABOS)
NASDAQ
$2.07+$0.04 (+1.87%)
Price as of Oct 22, 2026 7:56 PM EDT- $146.8MMarket Cap
- 9.73%1-Year Change
- BiotechnologyIndustry
ACUMEN PHARMA (ABOS)
$2.07+$0.04 (+1.87%)
ABOS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.03 | ||
Change | +$0.01 (+0.74%) | ||
Open | $2.00 | ||
High | $2.08 | ||
Low | $1.99 | ||
Previous Close | $2.02 | ||
Volume | 397,705 | ||
30-Day Average Volume | 591,592 | ||
1-Week Change | 16.33% | ||
1-Month Change | -21.62% | ||
1-Year Change | 9.73% | ||
3-Year Change | -41.33% | ||
5-Year Change | -86.06% | ||
Fundamentals | |||
Shares Outstanding | 72.3M | ||
Total Assets | $116.0M | ||
Market Cap | $146.8M | ||
Enterprise Value | $118.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.7M | ||
Free Cash Flow | -$18.1M | ||
EBIT | -$31.6M | ||
EBITDA | -$31.6M | ||
Net Working Capital | $68.7M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue